Natalia Rivera Team

Our research is dedicated to enhancing the understanding of the genetics and epigenetics of immune-mediated diseases, with a particular emphasis on sarcoidosis and rheumatoid arthritis. Our work aims to contribute to the development of innovative strategies for prevention and treatment, ultimately improving patient outcomes in these conditions.

Research focus

• Uncovering the molecular disease mechanisms in sarcoidosis and rheumatoid arthritis
• Integration of high-throughput molecular data for genomic signature discovery
• Biomarker discovery

Our research does not adhere to traditional methods. Instead, we employ human genetics and cutting-edge computational techniques to adopt an innovative research approach. This forward-thinking strategy not only allows us to explore new avenues but also holds the potential to revolutionize our understanding of these complex diseases.

Our team’s efforts center on big data and data-driven investigations, harnessing the power of vast datasets to shed light on disease pathogenesis and identify disease biomarkers and potential therapeutic targets, such as specific genes or pathways that can be targeted for drug applications.

The MESARGEN consortium, founded and lead by Natalia Rivera, is a pioneering international network that aims to revolutionize the genomics field of sarcoidosis globally. Its mission is to amass extensive sample sizes and ensure population ancestry diversity, addressing the research gaps in sarcoidosis studies. The collective clinical, molecular, and computational expertise in MESARGEN elevates the research’s robustness, paving the way for more accurate identification of molecular targets and realistic gene-based therapies.